MycoBiomDB – Record Details (MyCo_6466)

Biomarker Record Details

Database ID: MyCo_6466
DB IDMyCo_6466
TitleTargeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis
Year2023
PMID37478856
Fungal Diseases involvedCandidemia
Associated Medical ConditionSepsis
GenusCandida
Speciesalbicans
OrganismCandida albicans
Ethical StatementAll procedures were performed in accordance with ethical guidelines and approved animal license protocols of the Canton of Bern (BE3/18 and BE31/2021).
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBiopsy
Sample sourceKidney Tissue
Host GroupAnimal
Host Common nameMice
Host Scientific nameMus musculus
Biomarker NameIL-1Ra
Biomarker Full NameInterleukin-1 receptor antagonist
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationSwitzerland
CohortNone
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismCandida albicans represents the most common cause of fungal bloodstream infection; and despite adequate antifungal treatment, the overall mortality is 30%–40%, exceeding 60% in critically ill patients. C. albicans is normally contained by epithelial barrier immunity and occurs as commensal in half of the population. Inborn errors of immunity highlight the importance of interleukin (IL)-17-mediated pathways to avert mucocutaneous colonization, whereas functional neutrophil responses are critical to prevent systemic infec- tion. Accordingly, individuals with immunosuppression due to hematologic malignancies, organ transplantation, AIDS, or prolonged intensive care hospitalization are highly susceptible to invasive candidiasis. However, preceding systemic viral infections, or medical interventions that compromise physiological barrier function, such as indwelling devices, parenteral nutrition, and abdominal surgery, may predispose otherwise im- muno-competent hosts to disseminated Candida infection.
TechniquePCR
Analysis MethodqRT-PCR
ELISA kitsNone
Assay DataNone
Validation Techniques usedqRT-PCR, Flow Cytometry, Phagocytosis assay, Western blot, Immunohistochemistry and immunofluorescence
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone